Share

October 2013; 3 (5) Eye on Practice

Vagus nerve stimulation in the treatment of epilepsy

Payment policy perspectives

Saty Satya-Murti, Katie M. Shepard, Sandra L. Helmers
First published August 28, 2013, DOI: https://doi.org/10.1212/CPJ.0b013e3182a3931f
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1014

Share

Article Information

vol. 3 no. 5 431-435
DOI: 
https://doi.org/10.1212/CPJ.0b013e3182a3931f
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • First Published August 28, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Saty Satya-Murti, MD, FAAN,
    2. Katie M. Shepard, BA and
    3. Sandra L. Helmers, MD, MPH, FAAN
  1. Saty Satya-Murti, MD, FAAN,
    2. Scientific Advisory Boards:

    1. Between Jan 2011 and June 2013 participated in telephone consultations and/or in-person Medical Advisory Board meetings for: (1)Edwards LifeSciences 2011(2)United BioSource Corporation UBC (2010-13)(3)Bridgehead International (2011)(4)Medical Market Strategists (2012)(5)Pfizer(6) Simon-Kucher consultants (7)Stratas Consultants,(8) AstraZeneca (9) Avalere LLC

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Travel expenses for some of the entities in Answer #1, except #7. (1)Edwards LifeSciences 2011(2)United BioSource Corporation UBC (2010-13)(3)Bridgehead International (2011)(4)Medical Market Strategists (2012)(5)Pfizer(6) Simon-Kucher consultants (7) AstraZeneca (8) Avalere LLC

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Panelist, and later (2010-2011) Vice-Chair CMS-Medcac (Medicare Evidence Development and Coverage Advisory Committee). For the duration of the Medcac meeting, usually 1-2 days, I was considered an SGE (Special Government Employee).

    Consultancies:

    1. (1)Edwards LifeSciences 2011(2)United BioSource Corporation UBC (2010-13)(3)Bridgehead International (2011)(4)Medical Market Strategists (2012)(5)Pfizer(6) Simon-Kucher consultants (7)Stratas Consultants,(8) AstraZeneca (9) Avalere LLC

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Panelist, and later (2010-2011) Vice-Chair CMS-Medcac (Medicare Evidence Development and Coverage Advisory Committee). For the duration of the Medcac meeting, usually 1-2 days, I was considered an SGE (Special Government Employee).

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Katie M. Shepard, BA and
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. American Academy of Neurology, Associate Director Medical Economics

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Sandra L. Helmers, MD, MPH, FAAN
    4. Scientific Advisory Boards:

    1. Cyberonics Scientific advisory board UCB Scientific advisory board

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Cyberonics and UCB

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical procedures or imaging studies:

    1. I practice clinical epilepsy 43% of my time of about 10 % of my patients have vagus nerve stimulation.

    Research Support, Commercial Entities:

    1. Cyberonics multicenter health outcomes study UCB multicenter clinical trial UCB health outcomes research

    Research Support, Government Entities:

    1. CDC IPA

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Health Policy Consultant (SS-M), Santa Maria, CA; American Academy of Neurology (KMS), Minneapolis, MN; and Emory University (SLH), Atlanta, GA.
  1. Correspondence to:
    kshepard{at}aan.com
View Full Text

Article usage

Article usage: August 2013 to July 2022

AbstractFullPdfSource
Aug 201314008Highwire
Sep 2013347159Highwire
Oct 20134991590Highwire
Nov 2013357731Highwire
Dec 20132971116Highwire
Jan 2014209317Highwire
Feb 2014124912Highwire
Mar 20141401118Highwire
Apr 2014124910Highwire
May 201410746Highwire
Jun 20141221411Highwire
Jul 201411125Highwire
Aug 201411255Highwire
Sep 2014113612Highwire
Oct 2014119521Highwire
Nov 2014114110Highwire
Dec 201411219Highwire
Jan 201512314Highwire
Feb 20159803Highwire
Mar 201513229Highwire
Apr 2015118311Highwire
May 201512159Highwire
Jun 201510815Highwire
Jul 2015129418Highwire
Aug 201511916Highwire
Sep 201513811Highwire
Oct 201512744Highwire
Nov 2015106013Highwire
Dec 201511156Highwire
Jan 201613416Highwire
Feb 201646110Highwire
Mar 20164705Highwire
Apr 20163216Highwire
May 20164134Highwire
Jun 20164466Highwire
Jul 20164124Highwire
Aug 201632316Highwire
Sep 201674511Highwire
Oct 20163928Highwire
Nov 20164104Highwire
Dec 20165235Highwire
Jan 20174532Highwire
Feb 20172212Highwire
Mar 201738010Highwire
Apr 201740110Highwire
May 20174734Highwire
Jun 20173013Highwire
Jul 20172313Highwire
Aug 20171712Highwire
Sep 20172735Highwire
Oct 201741512Highwire
Nov 201725310Highwire
Dec 201723164Highwire
Jan 2018202517Highwire
Feb 2018152510Highwire
Mar 2018132010Highwire
Apr 2018221923Highwire
Apr 2018133pmc
May 2018205615Highwire
Jun 2018165916Highwire
Jun 2018122pmc
Jul 201822589Highwire
Aug 201815802Highwire
Aug 2018133pmc
Sep 201813383Highwire
Oct 201814393Highwire
Nov 201810255Highwire
Dec 20185363Highwire
Jan 20194215Highwire
Feb 20194277Highwire
Mar 20192285Highwire
Apr 20193349Highwire
May 20194397Highwire
Jun 20192223Highwire
Jul 201914710Highwire
Aug 20190234Highwire
Sep 20193257Highwire
Oct 20192237Highwire
Nov 20193259Highwire
Dec 20194407Highwire
Jan 20208149Highwire
Feb 20202197Highwire
Mar 20202234Highwire
Apr 20202165Highwire
May 20201286Highwire
Jun 20200144Highwire
Jul 20201287Highwire
Aug 20200185Highwire
Sep 202010256Highwire
Oct 20205383Highwire
Nov 20201113Highwire
Dec 20203135Highwire
Jan 20210175Highwire
Feb 20213186Highwire
Mar 20214265Highwire
Apr 20212154Highwire
May 20212233Highwire
Jun 20212126Highwire
Jul 20214820Highwire
Aug 202151911Highwire
Sep 20214125Highwire
Oct 202162233Highwire
Nov 20210716Highwire
Dec 202182211Highwire
Jan 20227146Highwire
Feb 20221195Highwire
Mar 20221166Highwire
Apr 20221135Highwire
May 202271610Highwire
Jun 2022055Highwire
Jul 2022043Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Topics Discussed

Alert Me